TherapeuticsMD, Inc. (TXMD)’s Stock Price Update:
TherapeuticsMD, Inc. (TXMD) stock figure shut its day with gain 6.05% and conclude at the price of $5.61, its 52 week- top value and changed 60.06% from its 52 week-lowest price value. Throughout its latest trading session, Stock negotiated with the total exchanged volume of 2.8 million shares. The average volume stands around 3.1 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 0.91. Relative volume is ratio between current volume and 3-month average value, intraday adjusted.
The company gives a ROE of -102.10%. The higher the ROE, the better the company is at creating profits. ROI is -59.80%. A beneficial result means that returns overreach costs. Analysts therefore review the investment a net obtain. The conflicting kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss. Return on Assets (ROA) ratio indicates how successful a company is relative to its total assets. The ROA is -68.00%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return.
ATR value of company was 0.29. The average true vary (ATR) could be a technical ANalysis indicator that measures volatility by rotten the complete vary of a plus worth for that amount. Truth vary indicator is that the greatest of the following: current high less this low, absolutely the worth of this high less the previous shut and also the definite quantity of this low less the previous shut. The common true vary could be a moving average, typically fourteen days, of truth ranges. It is a “New ideas in Technical commerce Systems.”
To review the TXMD previous performance, look at its past history, which highlighted below: During last 5 trades the stock fixed almost -3.61%. During last 30 days it showed the change of 8.93%. During last 3 month it remained at 12.88%. During last 1 year it moved at 3.70%. Along with these its (YTD) year to date performance is standing at 47.24%.
In USA Industry, TherapeuticsMD, Inc. (TXMD) have 246.98 million outstanding shares currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders. The company has shares float of 195.20 million. Float is the number of shares available for trading of a particular stock. Floating stock is calculated by subtracting closely-held shares and restricted stock from a firm’s total outstanding shares. Closely-held shares are those owned by insiders, major shareholders and employees, while restricted stock refers to insider shares that cannot be traded because of a temporary restriction such as the lock-up period after an initial public offering. A stock with a small float will generally be more volatile than a stock with a large float, apart from having limited liquidity and wider bid-ask spread. Because of these issues, institutional investors seldom invest in low-float stocks.
USA based company, TherapeuticsMD, Inc. (TXMD)’s latest closing price distance was -0.55% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 20.11% and 6.48% compared with the 20 Day Moving Average.
The stock price weekly volatility remained at 5.26% while volatility is standing at 4.83% for the month. Volatility refers to the amount of uncertainty or risk about the size of changes in a security’s value. A higher volatility means that a security’s value can potentially be spread out over a larger range of values. This means that the price of the security can change dramatically over a short time period in either direction. A lower volatility means that a security’s value does not fluctuate dramatically, but changes in value at a steady pace over a period of time. Commonly, the higher the volatility, the riskier the security.
Jennifer Medina- Technology
I am Jennifer Medina and I give “Nasdaqclick.com” the best and deepest insights into the latest happenings in the Innovation and technology segment. My journey started as an independent financial consultant for more than 13 years in the city and my craving to see the world has taken me to nations around the globe and given me the chance to report for a portion of the best news associations. Lately, I have started to use my envelopment and experience in healthcare financial news to become a full-time editor.
Address: 2648 Islington Ave
Toronto, ON M9V 2X5, Canada
Phone Number: +1 416 411 4123